Consistent with these beneficial changes in adipose tissue inflammation and lipid homeostasis, Ntn1Δmac mice showed improved insulin sensitivity compared to WT mice, suggesting that macrophage-specific targeting of netrin-1 may hold promise for the treatment of chronic inflammation and metabolic dysfunction in obesity. The gene discussed is NTN1; the disease is obesity disorder.